Progyny seesaws amid confusion over impact from Trump's IVF initiative
Source: SeekingAlpha
2025-10-17 13:11:40 ET
More on Progyny
- Progyny's Strong Fundamentals And Global Growth: Why I Choose To Buy
- Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript
- Progyny gains as White House reportedly eyeing proposal to make IVF more accessible
- Progyny raises full-year 2025 revenue guidance to $1.27B as member engagement and product expansion accelerate
- Seeking Alpha’s Quant Rating on Progyny
Read the full article on Seeking Alpha
For further details see:
Progyny seesaws amid confusion over impact from Trump’s IVF initiative
Pfizer Inc.
NASDAQ: PFE
PFE Trading
-0.48% G/L:
$26.765 Last:
14,932,304 Volume:
$27.02 Open:
PFE Latest News
PFE Stock Data
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
